Sentences with phrase «avian influenza vaccine»
«New NDV - H5NX avian influenza vaccine has potential for mass vaccination of poultry.»
https://www.sciencedaily.com/ Not exact matches
Physician Rachel David, a CSL spokeswoman, says the Australian vaccine is part of her country's cache of supplies to protect its population in the event of an avian influenza outbreak.
I understand China's desire to curtail the spread of Influenza A, both to buy more time to prepare a vaccine and to limit the opportunities that the virus will mix with the far more lethal avian influenza endemic to thInfluenza A, both to buy more time to prepare a vaccine and to limit the opportunities that the virus will mix with the far more lethal avian influenza endemic to thinfluenza endemic to the region.
The extracellular domain of the H5 or H7 protein of the respective avian influenza viruses was transplanted into the Newcastle disease virus vaccine strain LaSota in order to make the vaccine constructs.
When the researchers exposed chickens to lethal doses of the avian influenza virus and the Newcastle virus, birds inoculated with the recombinant vaccine produced antibodies against both viruses, offering protection against both diseases.
The current epizootic in the Far East caused by avian influenza virus A (H5N1) has led to real concern about the possibility of a new pandemic of influenza.12 Technological innovation, such as the use of new vaccines delivered by the intradermal route, offers great promise to change and improve on current immunization strategies.
CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.
In April 2017, Moderna published human data for its mRNA vaccine technology in Molecular Therapy, which showed that its first prophylactic vaccine candidate, mRNA - 1440 — an mRNA prophylactic vaccine against avian H10N8 influenza — induced high levels of immunogenicity and was safe and well tolerated.
The report «Veterinary / Animal Vaccines Market Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant)- Global Forecast to 2022», The global veterinary vaccines market is expected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9 % during the forecast period (2017 Vaccines Market Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant)- Global Forecast to 2022», The global veterinary vaccines market is expected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9 % during the forecast period (2017 vaccines market is expected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9 % during the forecast period (2017 - 2022).
Browse 148 Market Data Tables and 26 Figures spread through 161 Pages and in - depth TOC on «Veterinary / Animal Vaccines Market Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant)- Global Forecast to 2022» https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html Early buyers will receive 10 % customization on reports.
According to the American Veterinary Medical Association, «Currently, there is no USDA - licensed vaccine against H5N1 highly pathogenic avian influenza infection available for use in companion animals in the United States.»
Prepare solicitations and provide technical review (including safety and efficacy data) of proposals for avian influenza, classical swine fever, Rift valley fever, and other vaccines.